Biphosphonate-Associated Osteonecrosis of the Jaws: A Guide for the General Dental Practitioner

Barker, K. and Rogers, S. (2006) Biphosphonate-Associated Osteonecrosis of the Jaws: A Guide for the General Dental Practitioner. Dental Update, 33 (5). pp. 270-275. ISSN 0305-5000

Item not available from this archive.

Abstract

Bisphosphonates are used most commonly in the management of metastatic malignant disorders to bone and for osteoporosis. The number of patients on treatment is increasing. Although there is clear evidence of medical efficacy, there are increasing numbers of reports concerning bisphosphonate-associated osteonecrosis of the jaws. This side-effect poses significant problems and is very difficult to treat. The aim of this article is to outline the proposed pathogenesis, incidence, presenting signs and symptoms, and risk factors. Also, suggestions are made as to the most appropriate measures for prevention and management of bisphosphonate-associated jaw osteonecrosis. CLINICAL RELEVANCE: General dental practitioners have a key role to play in identifying patients at risk of developing bisphosphonate-associated osteonecrosis of the jaws, preventing occurrence of the condition and initiating early specialist referral.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
R Medicine > RK Dentistry
Divisions: Nursing and Midwifery
Date Deposited: 28 Feb 2011 15:47
URI: http://repository.edgehill.ac.uk/id/eprint/2657

Archive staff only

Item control page Item control page